NDRG2 Expression in Human Cancers, Especially Breast Cancer
Author Information
Author(s): Lorentzen Anders, Lewinsky Rikke H, Bornholdt Jette, Vogel Lotte K, Mitchelmore Cathy
Primary Institution: Roskilde University
Hypothesis
The study aims to examine levels of NDRG2 mRNA in several human cancers, focusing on breast cancer.
Conclusion
NDRG2 mRNA levels are significantly reduced in thyroid and breast cancer compared to normal tissue.
Supporting Evidence
- NDRG2 mRNA was reduced by at least 2-fold in almost a third of the tumor samples compared to normal tissue.
- A significant reduction in NDRG2 mRNA was observed in breast cancer and thyroid cancer samples.
- MYC mRNA levels were not significantly altered in breast cancer or thyroid gland cancer.
Takeaway
This study looked at a gene called NDRG2 in different cancers and found that it is lower in breast cancer, which might help us understand cancer better.
Methodology
The study used a Cancer Profiling Array and quantitative real-time RT-PCR to evaluate NDRG2 mRNA levels in paired normal and tumor samples.
Limitations
The sample sizes for some cancer types were small, which may limit the conclusions that can be drawn.
Participant Demographics
The study included samples from both male and female patients with various cancers, with mean ages ranging from 40.3 to 65.5 years.
Statistical Information
P-Value
0.004
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website